ArginMax Women's 30 day supply (caps)

ArginMax for Women was formulated specifically for women. Arginmax contains calcium and iron to help relieve fatigue issues specific to women. We have also replaced the American ginseng in the men's product with Damiana, an aromatic herb which helps calm anxiety and induce a relaxed state of mind. ArginMax for Women provides 100% of the RDA of vitamins A, C, E and the B-complex vitamins.

ArginMax safely enhances the female sexual experience by improving circulation. Sufficient blood flow is critical to female arousal, engorgement and lubrication.

Harper's Bazaar
Sex Drugs For Women?
March 2000

By Steve Fishman

"Another promising agent is the amino acid L-arginine—a nutrient, not a medicine (and therefore not FDA regulated)—which dilates blood vessels. When ArginMax, a supplement containing L-arginine, was given to a small group of women, two thirds reported increased clitoral sensitivity."

Research

The Daily Wellness Company, the makers of ArginMax, is committed to supporting scientific research. The Company has taken a methodical and scientific approach toward the development of ArginMax in order to establish the highest level of credibility and consumer trust. Preliminary results from a recent study on ArginMax for Women were presented at the international symposium entitled "New Perspectives In The Management of Female Sexual Dysfunction" held at Boston University on October 23, 1999. This meeting was attended and conducted by the world's leading experts on female sexual function. The final results were recently published in October-December 2001 issue of the peer-reviewed Journal of Sex and Marital Therapy.

RESULTS (Based on FSFI assessment):

70.6% improved in sexual desire level (placebo=41.9%), (p<0.01)
73.5% improved in satisfaction with sex life (placebo=37.2%), (p<0.01)
61.8% improved in sexual relationship with partner (placebo=34.9%), (p<0.01)
47.1% improved in frequency of orgasms (placebo=30.2%), (p<0.07)
52.9% improved in clitoral sensation to stimulation (placebo=34.9%), (p<0.06)